S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
NYSEAMERICAN:CTEK

CynergisTek Stock Forecast, Price & News

$1.48
-0.11 (-6.92%)
(As of 12/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.43
$1.59
50-Day Range
N/A
52-Week Range
$1.30
$2.90
Volume
135,635 shs
Average Volume
214,527 shs
Market Capitalization
$17.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.27
30 days | 90 days | 365 days | Advanced Chart
Receive CTEK News and Ratings via Email

Sign-up to receive the latest news and ratings for CynergisTek and its competitors with MarketBeat's FREE daily newsletter.


CynergisTek logo

About CynergisTek

CynergisTek, Inc. engages in the provision of cybersecurity, privacy, and compliance services for companies. It provides these services through assessment and technical testing, remediation, management, and validation services. The company was founded on September 7, 2017 and is headquartered in Austin, TX.

Headlines

See More Headlines

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:CTEK
Previous Symbol
NYSEMKT:CTEK
Employees
107
Year Founded
N/A

Sales & Book Value

Annual Sales
$18.87 million
Book Value
$2.17 per share

Profitability

Net Income
$-18.47 million
Pretax Margin
-103.93%

Debt

Price-To-Earnings

Miscellaneous

Free Float
10,836,000
Market Cap
$17.94 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/11/2021
Today
12/09/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

1.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -












CynergisTek (NYSEAMERICAN:CTEK) Frequently Asked Questions

How has CynergisTek's stock been impacted by COVID-19?

CynergisTek's stock was trading at $2.53 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CTEK stock has decreased by 41.5% and is now trading at $1.48.
View which stocks have been most impacted by COVID-19
.

Are investors shorting CynergisTek?

CynergisTek saw a decline in short interest in the month of October. As of October 29th, there was short interest totaling 120,500 shares, a decline of 27.1% from the October 14th total of 165,400 shares. Based on an average daily trading volume, of 334,900 shares, the short-interest ratio is presently 0.4 days.
View CynergisTek's Short Interest
.

How were CynergisTek's earnings last quarter?

CynergisTek, Inc. (NYSEAMERICAN:CTEK) issued its earnings results on Thursday, November, 11th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.22. CynergisTek had a negative trailing twelve-month return on equity of 48.97% and a negative net margin of 76.21%.
View CynergisTek's earnings history
.

Who are CynergisTek's key executives?

CynergisTek's management team includes the following people:
  • Michael H. McMillan, President, Chief Executive Officer & Director
  • Tim McMullen, Chief Operating Officer
  • Paul Thomas Anthony, Chief Financial Officer, Secretary & Treasurer
  • David S. Finn, Executive Vice President-Strategic Innovation
  • Benjamin Denkers, Executive Vice President-Operations

What other stocks do shareholders of CynergisTek own?

What is CynergisTek's stock symbol?

CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK."

Who are CynergisTek's major shareholders?

CynergisTek's stock is owned by a number of retail and institutional investors. Top institutional investors include Horton Capital Management LLC (6.18%), Essex Investment Management Co. LLC (2.28%) and Perritt Capital Management Inc. (1.26%). Company insiders that own CynergisTek stock include Dana Davis Sellers, John Lawrence Sr Flood Sr, Mark D Roberson, Michael Henry Mcmillan and Robert Mccashin.
View institutional ownership trends for CynergisTek
.

Which major investors are selling CynergisTek stock?

CTEK stock was sold by a variety of institutional investors in the last quarter, including Perritt Capital Management Inc..
View insider buying and selling activity for CynergisTek
or view top insider-selling stocks.

Which major investors are buying CynergisTek stock?

CTEK stock was purchased by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, and Horton Capital Management LLC. Company insiders that have bought CynergisTek stock in the last two years include Dana Davis Sellers, John Lawrence Sr Flood Sr, Mark D Roberson, Michael Henry Mcmillan, and Robert Mccashin.
View insider buying and selling activity for CynergisTek
or or view top insider-buying stocks.

How do I buy shares of CynergisTek?

Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CynergisTek's stock price today?

One share of CTEK stock can currently be purchased for approximately $1.48.

How much money does CynergisTek make?

CynergisTek has a market capitalization of $17.94 million and generates $18.87 million in revenue each year. The company earns $-18.47 million in net income (profit) each year or ($1.16) on an earnings per share basis.

How many employees does CynergisTek have?

CynergisTek employs 107 workers across the globe.

What is CynergisTek's official website?

The official website for CynergisTek is www.cynergistek.com.

Where are CynergisTek's headquarters?

CynergisTek is headquartered at 11940 JOLLYVILLE ROAD SUITE 300N, AUSTIN TX, 78759.

How can I contact CynergisTek?

CynergisTek's mailing address is 11940 JOLLYVILLE ROAD SUITE 300N, AUSTIN TX, 78759. The company can be reached via phone at (512) 402-8550, via email at [email protected], or via fax at 949-614-0701.


This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.